NAP1L1 and renal cell carcinoma: Moreover, Kaplan–Meier survival analysis from the TCGA RCC dataset showed that patients with lower NAP1L1 expression levels had longer survival times than those with higher NAP1L1 expression levels (Figure S1G, Table S10).